Condition
Hypofractionation
Total Trials
5
Recruiting
4
Active
4
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
5Total
Not Applicable (5)
Trial Status
Recruiting4
Enrolling By Invitation1
Clinical Trials (5)
Showing 5 of 5 trials
NCT05786742Not ApplicableRecruiting
Ultra Hypofractionnated Radiotherapy With HDR Brachytherapy Boost.
NCT06768125Not ApplicableEnrolling By Invitation
Hypofractionated Radiotherapy for HNSCC in Elderly Patients
NCT05364411Not ApplicableRecruiting
HYpofractionated, Dose-redistributed RAdiotherapy With Protons and Photons in HNSCC
NCT04472845Not ApplicableRecruiting
HYPofractionated Adjuvant RadioTherapy in 1 Versus 2 Weeks in High-risk Patients With Breast Cancer (HYPART).
NCT03920033Not ApplicableRecruiting
Salvage Hypofractionated Accelerated Versus Standard Radiotherapy for Biochemical Failure After Prostatectomy
Showing all 5 trials